-
Mashup Score: 6Integrating Novel Treatments for Severe FH Into Real-World Practice: A Heartening Interpretation of the Clinical Data - 3 year(s) ago
Check out this new Answers in CME activity on severe FH with Dr. Bhatt to earn credit. #HoFH #HeFH #CME #Cardiology #Lipidology #Endocrinology #CME
Source: www.answersincme.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
The ACC has collaborated with Medscape to create two Centers of Excellence on the topics of Cardiovascular Risk Reduction and Heart Failure. This collaboration will expand the reach of expert information, including best practices in CV medicine, to improve patient care. April 21, 2021 An Expert’s Guide to Managing Familial HypercholesterolemiaSeth J. Baum, MD, FACC, FAHA, FNLA, FASPCOne…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Have you read the newest ACC and Medscape collaborative piece on managing familial hypercholesterolemia by @SethJBaumMD? You can access it here today: https://t.co/tDKypWgwFb #HeFH
-
-
Mashup Score: 0Integrating Novel Treatments for Severe FH Into Real-World Practice: A Heartening Interpretation of the Clinical Data - 3 year(s) ago
Check out this new Answers in CME activity on severe FH with Dr. Bhatt to earn credit. #HoFH #HeFH #CME #Cardiology #Lipidology #Endocrinology #CME
Source: answersincme.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Can we achieve better LDL-C reduction in patients with severe FH?Join @DLBHATTMD as he discusses current and emerging therapeutic options to maximize care in these difficult-to-treat patients. Access this free activity👉https://t.co/UmQS7ncSIL #HeFH #HoFH #Lipids #LDL #CME #CE https://t.co/C2q78Dzp33
-
-
Mashup Score: 4FDA Approves Bempedoic Acid for Treatment of Adults With HeFH or Established ASCVD - American College of Cardiology - 3 year(s) ago
The U.S. Food and Drug Administration has approved bempedoic acid (Nexletol) for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C. The recommended dosage for the new drug, in combination with maximally tolerated statin therapy, is 180 mg administered orally…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
FDA Approves #BempedoicAcid for Treatment of Adults With #HeFH or #ASCVD - American College of Cardiology https://t.co/mp9Jc4PXum
-
Get expert insights from @DLBHATTMD on current and emerging strategies to maximize LDL-C reduction in patients with severe #HeFH #HoFH in this new Answers in CME activity. #Lipids #LDL #CME #CE #MedEd 👉https://t.co/Sj4Jw6g0xk https://t.co/alJJIvEdye